Twin Tree Management’s GSK GSK Stock Holding History

Twin Tree Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-83,300	Closed	-$4.09M	–	1460
2025 Q4	$4.09M	Sell	83,300 -224,700	-73%	-$10.5M	0.04%	581
2025 Q3	$13.3M	Sell	308,000 -249,600	-45%	-$9.75M	0.06%	397
2025 Q2	$21.4M	Buy	557,600 +269,800	+94%	+$10.3M	0.04%	460
2025 Q1	$11.1M	Sell	287,800 -192,400	-40%	-$7.04M	0.02%	629
2024 Q4	$16.2M	Buy	480,200 +218,700	+84%	+$7.87M	0.03%	531
2024 Q3	$10.7M	Buy	+261,500	New	+$10.7M	0.02%	633
2024 Q2	–	Sell	-149,400	Closed	-$6.4M	–	1465
2024 Q1	$6.4M	Sell	149,400 -403,200	-73%	-$16.6M	0.01%	753
2023 Q4	$20.5M	Buy	552,600 +58,500	+12%	+$2.1M	0.04%	461
2023 Q3	$17.9M	Buy	494,100 +222,600	+82%	+$7.9M	0.04%	385
2023 Q2	$9.68M	Sell	271,500 -426,200	-61%	-$15.3M	0.01%	622
2023 Q1	$24.8M	Sell	697,700 -1,012,200	-59%	-$35.4M	0.05%	343
2022 Q4	$60.1M	Sell	1,709,900 -930,300	-35%	-$31M	0.13%	143
2022 Q3	$77.7M	Buy	2,640,200 +2,456,440	+1,337%	+$93.1M	0.15%	105
2022 Q2	$10M	Buy	183,760 +52,240	+40%	+$2.88M	0.02%	646
2022 Q1	$7.16M	Sell	131,520 -520,400	-80%	-$28.3M	0.01%	799
2021 Q4	$35.9M	Hold	651,920	–	–	0.07%	245
2021 Q3	$31.1M	Buy	+651,920	New	+$32.7M	0.07%	258
2021 Q2	–	Sell	-109,920	Closed	-$4.9M	–	1454
2021 Q1	$4.9M	Sell	109,920 -4,400	-4%	-$200K	0.02%	653
2020 Q4	$5.26M	Buy	114,320 +109,920	+2,498%	+$5.05M	0.02%	611
2020 Q3	$207K	Buy	+4,400	New	+$220K	﹤0.01%	1027
2020 Q2	–	Sell	-465,040	Closed	-$22M	–	1549
2020 Q1	$22M	Buy	465,040 +17,600	+4%	+$939K	0.11%	173
2019 Q4	$26.3M	Buy	447,440 +386,880	+639%	+$21.5M	0.09%	178
2019 Q3	$3.23M	Buy	+60,560	New	+$3.12M	0.01%	581
2019 Q2	–	Sell	-6,480	Closed	-$338K	–	1365
2019 Q1	$338K	Hold	6,480	–	–	﹤0.01%	994
2018 Q4	$310K	Buy	6,480 +3,520	+119%	+$173K	﹤0.01%	1027
2018 Q3	$149K	Hold	2,960	–	–	﹤0.01%	943
2018 Q2	$149K	Buy	+2,960	New	+$149K	﹤0.01%	1015
2016 Q4	–	Sell	-18,400	Closed	-$992K	–	1240
2016 Q3	$992K	Sell	18,400 -31,840	-63%	-$1.75M	0.01%	675
2016 Q2	$2.72M	Buy	50,240 +44,320	+749%	+$2.33M	0.04%	403
2016 Q1	$300K	Sell	5,920 -33,120	-85%	-$1.65M	0.01%	931
2015 Q4	$1.97M	Buy	39,040 +22,880	+142%	+$1.17M	0.04%	418
2015 Q3	$777K	Buy	16,160 +13,680	+552%	+$712K	0.02%	627
2015 Q2	$129K	Buy	2,480 +2,080	+520%	+$117K	﹤0.01%	1128
2015 Q1	$23K	Buy	+400	New	+$22.9K	﹤0.01%	1084
2014 Q3	–	Sell	-7,600	Closed	-$508K	–	1046
2014 Q2	$508K	Sell	7,600 -33,680	-82%	-$2.28M	0.01%	679
2014 Q1	$2.76M	Buy	+41,280	New	+$2.79M	0.06%	368

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Twin Tree Management's GSK Position: Q1 2026 in Review

Twin Tree Management opened a new position in GSK (GSK) in Q1 2026: 594 shares worth $32.8K. The stake represents ﹤0.01% of the portfolio and ranks #1205 among its holdings. This is a return to the name: Twin Tree Management previously reported a position in GSK as recently as Q1 2025.

Twin Tree Management first reported a position in GSK in Q1 2014 and has held it in 22 quarters since. The position peaked at $22.3M in Q4 2021. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

Twin Tree Management held 594 shares of GSK worth $32.8K as of Q1 2026.
GSK was a new Twin Tree Management position in Q1 2026.
GSK made up ﹤0.01% of Twin Tree Management's portfolio in Q1 2026, its #1205 holding.
Twin Tree Management first reported a position in GSK in Q1 2014 and has held it in 22 quarters since.
Twin Tree Management's GSK position peaked at $22.3M in Q4 2021.
1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Twin Tree Management's 13F filing for Q1 2026, filed 14 May 2026.